Baxter International Inc.
(NYSE: BAX)

Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operated in two segments: BioScience and Medication Delivery. It is engaged in the medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors� offices, clinical and medical research laboratories, and by patients at home under physician supervision. Baxter manufactures products in 27 countries and sells the products in more than 100 countries. In September 2013, Baxter International Inc completed the acquisition of Gambro AB. Effective July 9, 2014, Baxter International Inc acquired AesRX LLC.

19.840 -

-2.430 (-10.91%)
价格区间 18.940 - 20.100   (6.12%)
开盘 19.520
昨收 22.270
19.830
买盘 236
19.840
卖盘 409
成交量 11,756,442
成交额 120,856,368
注释 -
数据延迟。最后一次更新12 Feb 2026 23:54.
数据提供商
查看所有活动

关于 Baxter Intl

Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operated in two segments: BioScience and Medication Delivery. It is engaged in the medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors� offices, clinical and medical research laboratories, and by patients at home under physician supervision. Baxter manufactures products in 27 countries and sells the products in more than 100 countries. In September 2013, Baxter International Inc completed the acquisition of Gambro AB. Effective July 9, 2014, Baxter International Inc acquired AesRX LLC.

Loading Chart...

Please login to view stock data and analysis